You fund Meridian health initiative – Previously KHP Ventures – About € 44.7 million has announced the launch of a new transitLantic fund with a total limited partner commitment.
The goal of the funds is to provide HealthThech superstisters both global and domestic growth opportunities, UK innovations assist in NHS and US healthcare markets.
Dr. Nadine Hachach-HaramMeridian Health Venture’s Co-Management Partner commented: “With this fund we want to supercharge the growth of the maximum committed innovation so that they can directly benefit the NHS patients and workforce as well as the larger economy in the UK. We are also creating an environment through transitLantric cooperation where the ambitious founder can scale at speed – both domesticly and internationally – reduce the gap between UK NHS and US Healthcare System to startThe “
Originally launched as KHP Venture in 2021, a team led by the Meridian Health Initiative has experience as entrepreneurs, investors, operators, controllers, educators, physicians and industrial leaders. Fund portfolio includes rapid scaling healthThek companies such as docla, DIPS, Patchwork, Timpa Health, Epian, IFAST Diagnostics, Pokdo, Fair Health, 52 North and Medisout.
The general partners of the firm are Daniel Dickens, Dr. Nadine Haram, Tim Irish and Dr. Pooja Sikka.
The company has also invested in promising Medtech spinouts from leading academic organizations in the UK, including Cambridge, Oxford, Imperial, Kings and Southampton. Significantly, 12 NHS clinical entrepreneurs are among the founding teams of the company in the portfolio of the fund.
Collectively, these portfolio companies have deployed their solutions across more than 100 NHS Trusts in the UK, many have expanded worldwide. Severals are already part of the major US health system like Cedar-Sinai.
Daniel DickensMeridian Health Ventures Co-Management Partner says: “As our founder, we launched this fund to ensure that the next generation of HealthThec breakthroughs can be shortened in the United Kingdom, not just invented here. We are proud to work with this group of top health system and healthcare investors on both sides of the Atlantic and are proud to work with talented founding teams on the portfolio of the fundThe “
According to the Meridian Health Initiative, Skeling, natively, remains a long-time challenge for the UK-founding HealthThek companies. Many were forced to move to the United States for growth, resulting in economic value for the UK and the chances of benefiting from the innovation of the NHS homeland.
Guy and St. Thomas NHS Foundation Trust, King College Hospital, and University College London Hospital-Pashapashi, including Ceders-Sinai Medical Center in the United States, supported both the United Kingdom in the United Kingdom and internationally to improve both the United States and internationally. Heartford Healthcare is also ready to join the upcoming funds with the rising speed of both sides of the Atlantic.
Teacher Ian ABBSGuy and St. Thomas NHS Foundation Trust mentions the CEO of the Trust: “NHS is facing one of the largest challenges in its history-how to provide high quality care against the background of the patient’s growing demand, increasing the patient’s significance and the background of the strength and money. NHS is not alone – most advanced health measures are jumping with the same basic questionsThe
“It is urgently to be invented why we have decided to be a founding company of KHP Venture and anchor of the Meridian Health Venture Fund. As a top NHS company, we are committed to increasing the acceleration in new digital and biomedical progress, such as this fund that invest in innovative start-ups, to provide better, fast and beautiful healthcare for all.“
Meridian Health Ventures are known as the first NHS-anchrod and Transtlantic Venture Capital Fund, focusing on the investment of the clinical inventors and converting the converting solution to the scale.
James d lorJD, Cedar-Sinai’s chief intellectual property officer and managing director of the Cedar-Sinai Health Initiative, added: “Our mission in Cedar-Sinai is provided with the best care of patients around the world and we believe that partnerships with talented innovators around the world will help us continue to achieve it. We have been working with the Meridian Health Venture team in the UK for years and see their mission as deeply integrated with us. We are fascinated by the quality and depth of the HealthThek founders in their portfolio and are interested in creating our cooperation as a partner of the fund.“
In October 2021, the firm launched with Europe’s first dedicated Mental Health Tech Fund – Innovations in Mental Health (IMH) Fund – Welcome Trust as anchor Investor and also with the NHS Foundation Trust in South London and Mods. Together, IMH funds and new transitLantic funds represent a total limited partner of about $ 44.7 million.
Alex TruebCEO and Meridian Health Venture Portfolio Company Epian’s co-founder says: “The story of the Appian began at NHS and we were lucky to have partners like Trust like Meridian Health Ventures and Guy and St Thomas NHS Foundation Trust. What started with the NHS Clinical Entrepreneur Program has become a mission to reach the global – it is fast taking care of patients from our work to the gypsline and wing. Meridian’s new translatantic fund creates a win for patients, physicians and health technology founders like usThe “
[publish_date
